Cargando…
The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175840/ https://www.ncbi.nlm.nih.gov/pubmed/35846101 http://dx.doi.org/10.1002/jha2.109 |
| _version_ | 1784722534282821632 |
|---|---|
| author | Isaksen, Kathrine T. Beiske, Klaus Smeland, Erlend B. Jørgensen, Judit Brodtkorb, Marianne Myklebust, June Helen Jerkeman, Mats Meriranta, Leo Karjalainen‐Lindsberg, Marja‐Liisa Leppä, Sirpa Scott, David W. Holte, Harald Blaker, Yngvild Nuvin |
| author_facet | Isaksen, Kathrine T. Beiske, Klaus Smeland, Erlend B. Jørgensen, Judit Brodtkorb, Marianne Myklebust, June Helen Jerkeman, Mats Meriranta, Leo Karjalainen‐Lindsberg, Marja‐Liisa Leppä, Sirpa Scott, David W. Holte, Harald Blaker, Yngvild Nuvin |
| author_sort | Isaksen, Kathrine T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9175840 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91758402022-07-14 The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma Isaksen, Kathrine T. Beiske, Klaus Smeland, Erlend B. Jørgensen, Judit Brodtkorb, Marianne Myklebust, June Helen Jerkeman, Mats Meriranta, Leo Karjalainen‐Lindsberg, Marja‐Liisa Leppä, Sirpa Scott, David W. Holte, Harald Blaker, Yngvild Nuvin EJHaem Short Reports John Wiley and Sons Inc. 2020-12-05 /pmc/articles/PMC9175840/ /pubmed/35846101 http://dx.doi.org/10.1002/jha2.109 Text en © 2020 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Short Reports Isaksen, Kathrine T. Beiske, Klaus Smeland, Erlend B. Jørgensen, Judit Brodtkorb, Marianne Myklebust, June Helen Jerkeman, Mats Meriranta, Leo Karjalainen‐Lindsberg, Marja‐Liisa Leppä, Sirpa Scott, David W. Holte, Harald Blaker, Yngvild Nuvin The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma |
| title | The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma |
| title_full | The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma |
| title_fullStr | The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma |
| title_full_unstemmed | The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma |
| title_short | The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma |
| title_sort | dlbcl90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase ii clinical trials with high‐risk diffuse large b‐cell lymphoma |
| topic | Short Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175840/ https://www.ncbi.nlm.nih.gov/pubmed/35846101 http://dx.doi.org/10.1002/jha2.109 |
| work_keys_str_mv | AT isaksenkathrinet thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT beiskeklaus thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT smelanderlendb thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT jørgensenjudit thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT brodtkorbmarianne thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT myklebustjunehelen thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT jerkemanmats thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT merirantaleo thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT karjalainenlindsbergmarjaliisa thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT leppasirpa thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT scottdavidw thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT holteharald thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT blakeryngvildnuvin thedlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT isaksenkathrinet dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT beiskeklaus dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT smelanderlendb dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT jørgensenjudit dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT brodtkorbmarianne dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT myklebustjunehelen dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT jerkemanmats dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT merirantaleo dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT karjalainenlindsbergmarjaliisa dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT leppasirpa dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT scottdavidw dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT holteharald dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma AT blakeryngvildnuvin dlbcl90geneexpressionassayidentifiesdoublehitlymphomaswithhighsensitivityinpatientsfromtwophaseiiclinicaltrialswithhighriskdiffuselargebcelllymphoma |